Cardiac Imaging

What Is the Best Imaging Study to Find an Embolic Source for Lower Extremity Arterial Occlusion?

·
What Is the Best Imaging Study to Find an Embolic Source for Lower Extremity Arterial Occlusion?

A 68-year-old patient with a history of atrial fibrillation presents to the emergency department with a cold, painful, and pulseless right leg. Vascular surgery is consulted, and an acute lower extremity arterial occlusion is confirmed. The clinical picture is highly suspicious for an embolic event rather than in-situ thrombosis from chronic peripheral artery disease. The immediate limb-threatening issue is being addressed, but the critical question remains: where did the embolus originate? Choosing the right next imaging study is crucial to prevent recurrence. This article provides a detailed clinical workflow for this specific scenario, guiding the selection of the next imaging study to identify the embolic source. According to the American College of Radiology (ACR) Appropriateness Criteria®, a transesophageal echocardiogram is Usually Appropriate as the next step in this workup.

Who Fits This Clinical Scenario?

This guidance applies to patients with a new, confirmed arterial occlusion in a lower extremity (e.g., femoral, popliteal, or tibial arteries) where an embolic etiology is suspected. The clinical suspicion for an embolic source is typically high in patients with known risk factors like atrial fibrillation, a recent myocardial infarction, valvular heart disease, or endocarditis. It also applies to patients without these risk factors but who present with an abrupt occlusion in an otherwise non-diseased arterial segment.

This workflow is specifically for identifying the source of the embolus, not for diagnosing the initial occlusion itself, which is presumed to be known. It is important to distinguish this scenario from several related but distinct clinical presentations:

  • Upper Extremity Arterial Occlusion: While also often embolic, the differential for an upper extremity source can include thoracic outlet syndrome or subclavian artery pathology, which may alter the initial imaging choice.
  • Mesenteric or Renal Arterial Occlusion: These scenarios often require a different imaging modality, such as Computed Tomography Angiography (CTA), as the primary study to both confirm the occlusion and evaluate for an aortic source simultaneously.
  • In-Situ Thrombosis: This guidance does not apply to patients whose occlusion is clearly due to progression of known, severe peripheral arterial disease (PAD), where the thrombus forms locally on a pre-existing atherosclerotic plaque.

What Diagnoses Are You Working Up in This Scenario?

When a lower extremity arterial occlusion is suspected to be embolic, the imaging workup is a search for the “smoking gun”—the origin of the clot. The differential is primarily focused on cardiac and aortic sources, as these account for the vast majority of cases.

Cardiac Thrombus: This is the most common cause of systemic arterial emboli. A thrombus can form in the left atrial appendage in the setting of atrial fibrillation, in the left ventricle following a myocardial infarction (especially with apical akinesis or aneurysm), or on diseased heart valves. These clots can be large and are prone to dislodging and traveling to distal arterial beds.

Complex Aortic Atheroma: The thoracic or abdominal aorta can harbor large, ulcerated, or mobile atherosclerotic plaques. These “shaggy aortas” can shed atheroembolic debris or serve as a nidus for thrombus formation, leading to what is often termed “aortoembolism.” This is a critical diagnosis to make, as it carries a high risk of recurrent embolization to multiple vascular territories.

Valvular Vegetations (Endocarditis): In patients with fever, new heart murmur, or risk factors like intravenous drug use, infectious endocarditis must be considered. Septic emboli can break off from infected heart valves (most commonly the mitral or aortic valves) and cause both arterial occlusion and systemic infection.

Less Common Sources: Other potential but less frequent sources include cardiac tumors (such as an atrial myxoma), paradoxical emboli (a venous clot that crosses a patent foramen ovale or other intracardiac shunt into the arterial circulation), and non-bacterial thrombotic endocarditis associated with malignancy or autoimmune disease.

Why Is Transesophageal Echocardiography the Recommended Study for This Presentation?

For a patient with a known lower extremity arterial occlusion and a suspected embolic source, the ACR rates US echocardiography transesophageal (TEE) as Usually Appropriate. The rationale is based on TEE’s superior ability to visualize the specific anatomical locations where the highest-yield embolic sources reside.

TEE places the ultrasound probe directly into the esophagus, immediately posterior to the heart. This provides an unobstructed, high-resolution view of key structures that are often poorly visualized on a standard transthoracic echocardiogram (TTE). TEE is exceptionally sensitive for detecting thrombus within the left atrial appendage, identifying small vegetations on the mitral and aortic valves, and characterizing complex, mobile atheroma in the descending thoracic aorta and aortic arch. Since these are the most common sources of emboli, TEE offers the most direct and effective diagnostic pathway.

While a transthoracic echocardiogram (TTE) is also rated Usually Appropriate and is a reasonable non-invasive first step, it has significant limitations. Poor acoustic windows due to body habitus or lung disease can render a TTE nondiagnostic for the critical posterior structures. It often fails to adequately visualize the left atrial appendage, the most common site of thrombus in atrial fibrillation.

A CTA of the chest, abdomen, and pelvis with IV contrast is another Usually Appropriate option. Its strength is providing a comprehensive view of the entire aorta, making it excellent for detecting aortic atheroma, aneurysm, or dissection. However, it is less sensitive than TEE for small cardiac thrombi or valvular vegetations. Furthermore, it involves a very high radiation dose (☢☢☢☢☢ 30-100 mSv) and requires iodinated contrast, which can be a concern in patients with renal insufficiency—a common comorbidity in this population.

In this specific scenario, TEE strikes the best balance. It directly interrogates the highest-probability sources with high sensitivity and specificity, involves no ionizing radiation (O 0 mSv), and provides functional information about the heart and valves that a CTA cannot.

What’s Next After Transesophageal Echocardiography? Downstream Workflow

The results of the TEE will guide the subsequent management and potential need for further imaging. The goal is to find the source to initiate appropriate therapy—usually anticoagulation—and prevent a devastating recurrence, such as a stroke.

  • If the TEE is positive: A definitive source, such as a left atrial appendage thrombus, a large mobile aortic plaque, or a valvular vegetation, dictates the next steps. A positive finding of a cardiac thrombus typically leads to initiation of therapeutic anticoagulation and consultation with cardiology for long-term management of the underlying condition (e.g., atrial fibrillation, heart failure). A finding of endocarditis requires urgent infectious disease and cardiothoracic surgery consultation.
  • If the TEE is negative: A negative TEE effectively rules out many of the most common cardiac sources. If clinical suspicion for an embolic source remains high, the focus shifts from the heart to the aorta. The next logical step would be to order a CTA or MRA of the chest, abdomen, and pelvis to search for a non-cardiac source like a complex aortic atheroma, which may be beyond the imaging window of the TEE.
  • If the TEE is indeterminate: In cases where findings are equivocal (e.g., spontaneous echo contrast or “sludge” in the left atrium without a discrete thrombus), the decision for anticoagulation becomes a matter of clinical judgment, balancing the risk of a recurrent embolus against the risk of bleeding. A cardiac MRI may be considered to better characterize myocardial tissue and function, especially if a post-MI ventricular thrombus is suspected but not definitively seen.

Pitfalls to Avoid (and When to Get Help)

In the workup of a suspected embolic source, several common pitfalls can delay diagnosis or lead to suboptimal outcomes. First, avoid “satisfaction of search” after finding one potential source; patients can have multiple sources (e.g., atrial fibrillation and a complex aortic plaque). Second, do not delay the source workup while managing the acute limb ischemia; the risk of a second, potentially more catastrophic embolic event (like a stroke) is high in the immediate aftermath. Third, remember that a “negative” TTE does not rule out a cardiac source; if suspicion is high, proceed to TEE. Finally, always consider the patient’s renal function before ordering a CTA with contrast. If a high-yield cardiac source is not found and an aortic source is suspected, consultation with a vascular medicine or cardiology specialist can help navigate the subsequent imaging and treatment decisions.

Related ACR Topics and Tools

This article focuses on one specific clinical scenario. For a comprehensive overview of all variants and imaging modalities related to this topic, please consult the parent guide. For additional decision support, the following GigHz resources can help you apply appropriateness criteria, understand imaging techniques, and discuss radiation safety with your patients.

Frequently Asked Questions

Why is a transesophageal echo (TEE) preferred over a transthoracic echo (TTE) in this scenario?

While a TTE is non-invasive and also rated ‘Usually Appropriate,’ a TEE is often preferred because it provides superior visualization of the left atrial appendage and the thoracic aorta. These are two of the most common locations for a thrombus or complex plaque that can cause a lower extremity embolus, and they are frequently missed on a standard TTE due to poor acoustic windows.

If the patient has known atrial fibrillation, is imaging for a source still necessary?

Yes. While atrial fibrillation is a major risk factor and strongly suggests a cardiac source, imaging is still crucial. It confirms the presence of a thrombus (most often in the left atrial appendage), which solidifies the decision for long-term anticoagulation. It also rules out other concurrent sources, such as a complex aortic plaque or valvular vegetation, which might require different management.

When should I order a CTA of the chest, abdomen, and pelvis instead of an echocardiogram?

A CTA of the chest, abdomen, and pelvis is an excellent choice if the clinical suspicion for an aortic source (e.g., from severe, diffuse atherosclerosis or a known aneurysm) is higher than for a cardiac source. It is also the next logical step if a high-quality TEE is negative but clinical suspicion for an embolic source remains high, as it provides a comprehensive evaluation of the entire aorta.

What if the patient is too unstable for a TEE?

In a hemodynamically unstable patient, a bedside TTE is the most appropriate initial study. It is rapid, non-invasive, and can quickly identify major issues like a large left ventricular thrombus or severe valvular dysfunction. A TEE requires sedation and is a semi-invasive procedure, so it should only be performed once the patient is sufficiently stabilized.

Does this workup change if the patient is young and has no traditional risk factors?

Yes, the differential diagnosis broadens in a young patient. While a TEE is still a key study, the workup should also more strongly consider a paradoxical embolus. This may involve performing a ‘bubble study’ during the echocardiogram to look for a patent foramen ovale (PFO) or other intracardiac shunt. A workup for hypercoagulable states should also be initiated.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026